BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26242529)

  • 1. The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa.
    Snyman LC; Dreyer G; Botha MH; van der Merwe FH; Becker PJ
    S Afr Med J; 2015 Jan; 105(2):115-20. PubMed ID: 26242529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South Africa.
    Snyman LC; Dreyer G; Visser C; Botha MH; van der Merwe FH
    S Afr Med J; 2015 Mar; 105(3):191-4. PubMed ID: 26294825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vaccine and cervical cancer screen (VACCS) project: acceptance of human papillomavirus vaccination in a school-based programme in two provinces of South Africa.
    Botha MH; van der Merwe FH; Snyman LC; Dreyer G
    S Afr Med J; 2015 Jan; 105(1):40-3. PubMed ID: 26046162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. School-based human papillomavirus vaccination: An opportunity to increase knowledge about cervical cancer and improve uptake of screening.
    Dreyer G; van der Merwe FH; Botha MH; Snyman LC; Constant D; Visser C; Harvey J
    S Afr Med J; 2015 Nov; 105(11):912-6. PubMed ID: 26632317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials.
    Dreyer G; Botha MH; Snyman LC; Visser C; Burden R; Laubscher N; Grond B; Richter K; Becker PJ; Harvey J; van der Merwe FH
    Int J Gynecol Cancer; 2022 May; 32(5):592-598. PubMed ID: 35078829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing human papillomavirus vaccines into the health system in South Africa.
    Botha MH; Dochez C
    Vaccine; 2012 Sep; 30 Suppl 3():C28-34. PubMed ID: 22939017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and cervical cancer risk perception and vaccine acceptability among adolescent girls and young women in Durban, South Africa.
    Russell VL; Ogilvie G; Beksinska M; Nyrenda M; Mitchell-Foster S; Lavoie J; Harder H; Wood B; Smith P; Dietrich JJ; Smit J; Brockman MA; Gray G; Kaida On Behalf Of The Ayazazi Research Team A
    S Afr Med J; 2020 Aug; 110(9):887-893. PubMed ID: 32880274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic factors predicting mother's cervical screening and daughter's HPV vaccination uptake.
    Spencer AM; Roberts SA; Brabin L; Patnick J; Verma A
    J Epidemiol Community Health; 2014 Jun; 68(6):571-7. PubMed ID: 24567443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
    Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
    Front Public Health; 2022; 10():799984. PubMed ID: 35174123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
    Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
    Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model.
    Shafer LA; Jeffrey I; Elias B; Shearer B; Canfell K; Kliewer E
    Vaccine; 2013 Oct; 31(42):4848-55. PubMed ID: 23933332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
    Demarteau N; Van Kriekinge G; Simon P
    Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High uptake of Gardasil vaccine among 9 - 12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa.
    Moodley I; Tathiah N; Mubaiwa V; Denny L
    S Afr Med J; 2013 May; 103(5):318-21. PubMed ID: 23971122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.